Stocks · Health care · Services-Medical Laboratories

GRAIL, Inc.

GRAL Clue Score54
United States Fiscal year ends December CIK 0001699031 Results filed 4 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Joshua J. Ofman
15 Oct 2026
Chief Executive Officer
Sold on a plan
2,114
$138.79
$293.39K
Joshua J. Ofman
15 Oct 2026
Chief Executive Officer
Sold on a plan
6,034
$137.63
$830.47K
Joshua J. Ofman
15 Oct 2026
Chief Executive Officer
Sold on a plan
7,052
$136.83
$964.95K
Joshua J. Ofman
15 Oct 2026
Chief Executive Officer
Sold on a plan
3,400
$135.44
$460.51K
Joshua J. Ofman
15 Oct 2026
Chief Executive Officer
Sold on a plan
1,000
$134.38
$134.38K
Joshua J. Ofman
15 Oct 2026
Chief Executive Officer
Sold on a plan
400
$133.12
$53.25K
Aaron Freidin
21 Sep 2026
Chief Financial Officer
Sold on a plan
521
$95.00
$49.50K
Aaron Freidin
21 Sep 2026
Chief Financial Officer
Sold on a plan
1,800
$93.92
$169.05K
Aaron Freidin
21 Sep 2026
Chief Financial Officer
Sold on a plan
1,779
$92.26
$164.14K
Aaron Freidin
27 Aug 2026
Chief Financial Officer
Sold on a plan
7,900
$85.01
$671.58K
Joshua J. Ofman
27 Aug 2026
Chief Executive Officer
Sold on a plan
5,000
$85.02
$425.10K
Joshua J. Ofman
16 Oct 2025
President
Sold on a plan
6,114
$82.01
$501.41K
Joshua J. Ofman
15 Oct 2025
President
Sold on a plan
8,865
$76.03
$673.98K
Joshua J. Ofman
2 Oct 2025
President
Sold on a plan
9,692
$64.00
$620.31K
Aaron Freidin
15 Jul 2025
Chief Financial Officer
Sold on a plan
8,000
$38.93
$311.44K
Joshua J. Ofman
30 Jun 2025
President
Sold on a plan
9,692
$52.00
$503.98K
Joshua J. Ofman
12 Jun 2025
President
Sold on a plan
9,692
$42.30
$410.02K

What was left out

Form 4 filings counted 100
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 17
Sales straight out of an exercise 8
Sales at will 49
Transactions with no price 0
Shares from compensation/vesting 28,964,338
History held since 24 Jun 2024